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Oxidation of Atg3 and Atg7 mediates inhibition of
autophagy
Karen Frudd1, Thomas Burgoyne2,3 & Joseph Robert Burgoyne1
Macroautophagy (autophagy) is a crucial cellular stress response for degrading defective
macromolecules and organelles, as well as providing bioenergetic intermediates during
hypoxia and nutrient deprivation. Here we report a thiol-dependent process that may account
for impaired autophagy during aging. This is through direct oxidation of key autophagy-
related (Atg) proteins Atg3 and Atg7. When inactive Atg3 and Atg7 are protected from
oxidation due to stable covalent interaction with their substrate LC3. This interaction
becomes transient upon activation of Atg3 and Atg7 due to transfer of LC3 to phosphati-
dylethanolamine (lipidation), a process crucial for functional autophagy. However, loss in
covalent-bound LC3 also sensitizes the catalytic thiols of Atg3 and Atg7 to inhibitory oxi-
dation that prevents LC3 lipidation, observed in vitro and in mouse aorta. Here ﬁndings
provide a thiol-dependent process for negatively regulating autophagy that may contribute to
the process of aging, as well as therapeutic targets to regulate autophagosome maturation.
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Macroautophagy (hereafter referred to as autophagy) is acatabolic process that delivers cellular components tolysosomes for degradation. This process of removing
aged or dysfunctional macromolecules and organelles is critical in
maintaining cellular homeostasis. The regulation of the autop-
hagy pathway is controlled by the gatekeeper protein, mammalian
target of rapamycinm (mTOR)1. Inhibition of mTOR by energy
deprivation, hypoxia, or amino acid withdrawal allows autopha-
gosome nucleation, by activating unc-51 like autophagy activating
kinase 1 (ULK1), and releasing beclin1 from its inhibitory com-
plex with B-cell lymphoma 2 (Bcl-2)2,3. Once nucleated the
maturation of the growing autophagosome requires the activities
of two conjugation pathways. Firstly, the E1-like and E2-like
enzymes Atg7 and Atg10 constitutively conjugate Atg5 to Atg12
through a glycyl lysine isopeptide bond4. The covalently bound
Atg5 and Atg12 then acts as an E3-like enzyme in the second
conjugation pathway, where LC3 is attached to phosphatidy-
lethanolamine (PE). The conjugation of LC3 to PE (LC3II) is
mediated by the E1-like and E2-like enzymes Atg7 and Atg3
respectively5. This process occurs once autophagy is initiated, as
Atg3 is regulated by a membrane-curvature-sensing domain,
which switches on enzyme activity only at highly curved mem-
brane surfaces, characteristic of a growing autophagosome6. As
conjugation of LC3 to PE only occurs after induction of autop-
hagy, its detection has become the gold standard for measuring
activation of this catabolic process. However, the conjugation of
PE to LC3 is also involved in autophagosome maturation as it
contributes to cargo recognition, membrane extension, and clo-
sure of the autophagosome membrane7,8. More importantly, LC3
is also crucial in autophagosome−lysosome fusion and for
degradation of the inner autophagosomal membrane9,10. The
importance of LC3 lipidation is underscored by the neonatal
lethality of knocking out either Atg3 or Atg711. In addition,
conditional knockout of Atg3 or Atg7 impairs autophagosome
formation and starvation-induced degradation of proteins and
organelles12,13. The loss in autophagic renewal is also a key fea-
ture of aging that leads to accumulation of damaged proteins and
organelles, resulting in cellular dysfunction. This explains why
model organisms with decreased autophagy have accelerated
aging, whereas enhanced stimulation may have potent anti-aging
and disease-preventing effects14. Here we describe a molecular
mechanism for the acute inhibition of amino acid starvation-
induced LC3 lipidation, under conditions of oxidative stress due
to the direct oxidation of Atg3 and Atg7. This is highly relevant as
perturbations in cellular redox have been causatively linked to
aging and the pathogenesis of many diseases, which are also
broadly characterized by dysregulated autophagy15–21. In addi-
tion, stable covalent complexes between LC3 and both Atg3 and
Atg7 were identiﬁed and found to decrease upon autophagy
induction, which sensitized these enzymes to oxidative inhibition.
This thiol-dependent process for inhibiting LC3 lipidation was
also observed in aged mouse aorta, thus likely causative in
decreasing the ability to stimulate autophagy during starvation.
Therefore, our ﬁndings provide insights into the regulation of
autophagy, but also a process that is likely to contribute to the
process of aging.
Results
Rapid oxidative inhibition of LC3 lipidation. The formation of
LC3II induced by amino acid starvation in human embryonic
kidney 293 (HEK) cells and rat aortic smooth muscle cells (SMC)
was dose-dependently inhibited by H2O2 treatment (Figs. 1a–c).
This loss in LC3 lipidation due to increased intracellular reactive
oxygen species (ROS) did not impact on cell viability, which was
enhanced by the rapid inducer of apoptosis raptinal
(Supplementary Fig. 1A–F)22. Therefore, impaired LC3 lipidation
by H2O2 was likely mediated by direct inhibition of the autophagy
pathway. Consistent with these ﬁndings we observed an increase
in the localization of LC3 to autophagic vacuoles in SMC during
amino acid starvation, which then was attenuated by H2O2 co-
treatment (Figs. 1d, e, Supplementary Fig. 2A, B). In addition,
H2O2 co-treatment also decreased autophagic vacuole formation
(Supplementary Fig. 2C). To further assess the loss in LC3 lipi-
dation with H2O2 treatment we used the late phase inhibitor of
autophagy baﬁlomycin A1. Baﬁlomycin A1 increased the accu-
mulation of starvation-induced LC3II that remained inhibited by
H2O2, meaning a loss in PE conjugation was responsible, as
opposed to increased turnover of LC3II. The inhibition of LC3
lipidation by H2O2 following amino acid withdrawal persisted
over several hours and, consistent with loss in autophagy, pre-
vented starvation-induced lysosomal degradation of p62 (Sup-
plementary Fig. 3A). In addition, as an acute 30-min treatment
with H2O2 was sufﬁcient to block autophagy (Supplementary
Fig. 3B), this suggested the effect was due to direct enzyme oxi-
dation rather than transcriptional regulation. Certainly, this was
consistent with LC3A gene expression, which remained unaltered
by H2O2 treatment (Supplementary Fig. 3C). In addition, this
process was independent of protein translation or proteasomal
degradation, as amino-acid-starved cells co-treated with cyclo-
heximide or MG132 had impaired LC3II formation when
exposed to H2O2 (Supplementary Fig. 3D, E).
Atg3 and Atg7 form stable covalent complexes with LC3.
Activation of autophagy with the cell-permeable peptide tat-
beclin1, bypassing mTOR regulation, was also blocked by H2O2
without compromising cell viability, thus placing the inhibitory
mechanism that is rationally mediated by protein oxidation
downstream of beclin1 (Fig. 1f, Supplementary Fig. 3F–H)23.
Consequently, we next assessed the conjugation systems that lay
downstream of beclin1 responsible for the lipidation of LC324,
searching for the target protein(s) that are oxidized by H2O2, as
they would likely mediate the inhibition of autophagy. A key way
in which proteins can be regulated by oxidants is through
induction of regulatory disulﬁde bonds, including interprotein
complex formation25. Formation of these complexes in response
to H2O2 was assessed using non-reducing sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE), which keeps any
such disulﬁdes that may mediate the inhibition of LC3II forma-
tion intact. Here we found the constitutive thiol-dependent
conjugation of Atg5 to Atg12 needed for LC3 lipidation was
unaffected by H2O2 treatment in HEK cells (Fig. 2a)26. This is
perhaps unsurprising considering how rapidly H2O2 inhibited
LC3II formation. However, on assessing Atg3 and Atg7 in HEK
cells under non-reducing conditions, we observed higher mole-
cular weight complexes (approximately an additional 15 kDa)
consistent with covalent-bound LC3 (Fig. 2a). This was corro-
borated by a previous study showing the yeast homolog of LC3,
Atg8, can form stable intracellular thioester complexes with Atg3
and Atg75. The identity of higher molecular complexes for Atg3
and Atg7 were substantiated as they were also observed on an
LC3 immunoblot (Fig. 2b). These complexes were due to a thio-
ester linkage as they could be hydrolyzed by hydroxylamine. In
addition, the thio-ester bond between LC3 and either Atg3 or
Atg7 could be cleaved by the thiol-reducing agent beta-
mercaptoethanol. The identity of the higher molecular weight
complexes was further supported by co-immunoprecipitation
studies. Here higher molecular weight forms of Atg3 and Atg7
were co-puriﬁed when myc-tagged LC3 was immunoprecipitated,
thus further substantiating stable covalent interaction with LC3
(Fig. 2c). The higher molecular weight covalent complexes
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observed for Atg3 and Atg7 comprised of LC3A and LC3B, as
well as the essential autophagy regulators GABA(A) receptor-
associated protein-like (GABARAPL) isoforms 1 and 2 (Supple-
mentary Fig. 4A). Both GABARAPL1 and 2 formed complexes at
molecular weights consistent with bound Atg3 and Atg7, which
decreased following an hour of amino acid withdrawal and could
be selectively cleaved using hydroxylamine. Consistent with the
oxidative inhibition of enzymes involved in LC3II formation, the
lipidation of GABARAPL1 by amino acid deprivation was also
attenuated by H2O2 (Supplementary Fig. 4B).
LC3 III
Actin
LC3 I
II
Actin
–
– – – – – –
–
+ + + + + +
++++++++++EBSS
EBSS
100 nM Bafilomycin
100 nM Bafilomycin
1.4
1.2 4.5
4
3.5
3
2.5
1.5
1
0.5
0
2
1
0.8
***
***
***
† †
†
††† †††
††††††††
LC
3I
I/a
ct
in
 (a
.u.
)
LC
3I
I/a
ct
in
 (a
.u.
)
LC
3I
I/a
ct
in
 (a
.u.
)
LC
3I
I/a
ct
in
 (a
.u.
)
0.6
0.4
0.2
LC3
Actin
2.5
2.0
***
††
†† †
†
†
†
†† †††
†††*
1.5
1.0
0.5
0
–
–
– – – – –
– ––
– –
– –
–
–
–+ + +
200 200100500 500 200 200100500 500
15 kDa
37 kDa
15 kDa
37 kDa
15 kDa
37 kDa
+
+ + + + + + +
++++
I
II
0
Control
Control
EBSS
EBSS EBSS +
100 μM H2O2
EBSS +
200 μM H2O2
EBSS +
500 μM H2O2
EBSS + 100 μM H2O2
EBSS + 100 μM H2O2
10
*
LC
3 
pu
nc
ta
/c
el
l 8
6
4
2
0
EBSS +
100 μM H2O2
EBSS +
200 μM H2O2
EBSSControl
**
† ††
12
LC
3-
po
sit
ive
 a
ut
op
ha
gi
c
va
cu
o
le
s/
10
00
 μ
m
2
10
8
6
4
2
0
LC3
25 μM
15 kDa
37 kDa
I
II
Actin
–
0
***
0 00200 200500 500
– –
+ + + + + +
++++––
–50 μM Tat-beclin1
H2O2 (μM)
100 nM Bafilomycin
6
5
4
3
2
1
0
EBSS + 200 μM H2O2
EBSS + 200 μM H2O2
EBSS +
10 μM
H2O2
EBSS +
25 μM
H2O2
EBSS +
50 μM
H2O2
EBSS +
100 μM
H2O2
EBSS +
200 μM
H2O2
200 μM
H2O2
500 μM
H2O2
200 μM
H2O2
100 μM
H2O2
50 μM
H2O2
25 μM
H2O2
10 μM
H2O2
Control
Control
EBSS
EBSS
1 μm 1 μm
1 μm1 μm
Control EBSS
– Bafilomycin A1
+ Bafilomycin A1
– Bafilomycin A1
+ Bafilomycin A1
– Bafilomycin A1
+ Bafilomycin A1
EBSS +
100 μM H2O2
EBSS +
200 μM H2O2
EBSS +
50 μM H2O2
Control Control Tat-beclin1 Tat-beclin1
+ 200 μM H2O2
Tat-beclin1
+ 500 μM H2O2
EBSS EBSS +
200 μM H2O2
EBSS +
100 μM H2O2
0 0 10 10 25 25 50 50 100 100 200 200 20010050000 20010050000H2O2 (μM)
EBSS
H2O2 (μM)
H2O2 (μM)
– –+ + – + – + – + – +
a b
c d
e
f
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02352-z ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:95 |DOI: 10.1038/s41467-017-02352-z |www.nature.com/naturecommunications 3
Atg3 and Atg7 are susceptible to catalytic thiol oxidation. The
quantity of covalent-bound LC3 decreased in HEK cells and SMC
during amino acid withdrawal due to activation of Atg3 and Atg7
(Figs. 2a, d). In addition, after H2O2 treatment loss in stable
covalent LC3 complexes following amino acid withdrawal was
sustained in SMC. This is consistent with maintained upstream
stimulation of the Atg3 and Atg7 complex under oxidizing con-
ditions, but potentially decreased enzymatic activity due to direct
oxidation. Therefore, as these enzymes are end-mediators in
conjugating PE to LC3, this indicates that they are the likely
targets of oxidation responsible for H2O2-dependent inhibition of
LC3 lipidation. This was supported by the H2O2-dependent for-
mation of an intermolecular disulﬁde complex between Atg3 and
Atg7 in SMC only after amino acid starvation (Figs. 2d, e). The
select formation of a disulﬁde complex after amino acid starva-
tion is consistent with increased thiol availability on Atg3 and
Atg7, due to a decrease in covalent LC3 interaction. The oxidized
complex observed for Atg3 and Atg7 was at the same molecular
weight, and with a mass consistent for a covalent heterodimer
comprising of each protein (Fig. 2e). The identity of the con-
joining bond was conﬁrmed as intermolecular disulﬁde, as it was
lost with beta-mercaptoethanol but not hydroxylamine treatment.
In addition, consistent with oxidation occurring at the active site
cysteine of Atg3 and Atg7, the oxidized complex did not contain
LC3, as it resolved at the same molecular weight after hydro-
xylamine treatment. The formation of an intermolecular disulﬁde
between Atg3 and Atg7 is consistent with the crystal structure of
the yeast complex, where the proximal exposed catalytic cysteine
of each enzyme is closely aligned, allowing LC3 transfer, but also
disulﬁde formation (Fig. 2f)27. Although disulﬁde dimerization of
Atg3 and Atg7 was not observed in HEK cells, likely due to
increased LC3 occupancy on Atg3, reversible oxidation still
occurred and was detected using the PEG-switch assay (Fig. 2g).
The extent of reversible Atg3 and Atg7 oxidation in H2O2-treated
HEK cells was comparable to that of the known redox sensor,
cyclic guanosine monophosphate (cGMP)-dependent protein
kinase 1 alpha (PKG1α)28. In addition to Atg3 and Atg7, Atg4B
and Atg10 were also found to be sensitive to oxidation. However,
oxidation of Atg10 is unlikely to impair LC3 lipidation under the
experimental conditions studied, as H2O2 treatment did not
impact on the conjugation of Atg5 to Atg12 (Fig. 2a, Supple-
mentary Fig. 5A). Also, the oxidation of Atg4B previously
described29 is unlikely to explain loss in LC3 lipidation following
acute H2O2 treatment, due to constitutive enzyme activity30. Here
loss in LC3 lipidation was independent of Atg4B oxidation, as a
truncated LC3 (ΔC) mutant not requiring protease activity,
underwent amino-acid-starved lipidation, which was attenuated
by H2O2 to the same extent as wild-type protein (Fig. 2h).
Therefore, loss in LC3 lipidation is likely due to oxidation of Atg3
or Atg7. This is consistent with the select activation of Atg3 and
Atg7 upon stimulation of autophagy, with disulﬁde formation or
potential S-glutathiolation preventing interaction and lipidation
of LC3.
Oxidation of Atg3 and Atg7 prevents LC3 lipidation. To fur-
ther assess in greater detail the impact of protein oxidation on
LC3II formation, we performed in vitro lipidation assays6. Once
again, we observed higher molecular weight complexes for Atg3
and Atg7 consistent with their stable covalent interaction with
LC3 under non-reducing conditions (Fig. 3a), which were lost
with beta-mercaptoethanol treatment. In addition, we observed a
higher molecular weight complex when only Atg7 and LC3 were
present, which had a mass consistent with an oxidized Atg7
disulﬁde dimer. The formation of an Atg7 disulﬁde dimer is likely
an artifact of its high concentration in an in vitro model system,
as the oxidized complex observed in SMC was of a lower mole-
cular weight and comprised of both Atg3 and Atg7. However, the
formation of a stable complex between Atg3 and LC3 was
dependent on Atg7. This is consistent with the proposed
mechanism of LC3 lipidation, where LC3 binds to Atg7 before
being transferred to Atg3, where it is then conjugated to PE5. In a
complete cell-free reaction mixture, the lipidation of LC3
increased over 60 min (Fig. 3b, Supplementary Fig. 5B). As well as
lipidated LC3, an additional form (middle band) can also be
observed that is likely an adenylated intermediate6. Here the
increase in LC3 lipidation in a complete cell-free reaction was
inhibited by S-glutathiolation, induced by the addition of oxidized
glutathione (GSSG) (Fig. 3c, Supplementary Fig. 5C). The addi-
tion of GSSG also led to increased accumulation of unbound Atg3
and Atg7, consistent with catalytic cysteine oxidation through
enhanced S-glutathiolation.
Identifying sites of Atg3 and Atg7 oxidation. The interaction of
Atg3 and Atg7 is required for LC3 lipidation as it positions the
catalytic thiol of each enzyme into close proximity to allow
transfer of LC327. Therefore, we next assessed if interaction
between Atg3 and Atg7 was impacted by enzyme oxidation. In
fed cells and those deprived of amino acids, a large proportion of
interacting Atg3 and Atg7 could be observed using a proximity
ligation assay (Fig. 4a). In amino-acid-deprived cells exposed to
H2O2, there was a loss in Atg3 and Atg7 interaction. However,
this interaction was unaffected by H2O2 in cells cultured in
complete media. These ﬁndings are consistent with a loss in
covalent LC3 interaction that exposes catalytic thiols on Atg3 and
Atg7 to oxidation, with oxidative modiﬁcation preventing phy-
sical enzyme interaction. As oxidation of Atg3 and Atg7 prevents
LC3 lipidation, we next attempted to prevent this process by
increasing the pool of reduced Atg7. The overexpression of Atg7
in HEK cells led to an increase in covalent-bound LC3 (Fig. 4b).
This further substantiated the presence of a stable covalent
complex between these proteins, as its formation directly
Fig. 1 LC3 lipidation is inhibited by H2O2. a The withdrawal of amino acids from SMC for 1 h induces LC3 lipidation that decreased in a concentration-
dependent manner by H2O2 co-treatment. The graph below shows quantiﬁcation of LC3 lipidation from treated SMC. b Loss of LC3 lipidation in amino-
acid-starved SMC is maintained when fusion between autophagosomes and lysosomes is inhibited by baﬁlomycin A1. The graph below shows
quantiﬁcation of LC3 lipidation from treated SMC in the presence or absence of baﬁlomycin A1. c In HEK cells H2O2 also attenuates LC3 lipidation in
response to 1 h amino acid withdrawal in the presence or absence of baﬁlomycin A1. The graph below shows quantiﬁcation of LC3 lipidation from treated
HEK cells. d Electron microscopy of immunogold-labeled LC3 shows loss of LC3II-positive autophagic vacuoles (arrows) in amino-acid-starved SMC
exposed to H2O2. The graph below shows quantiﬁcation of LC3II-positive autophagic vacuoles in treated SMC. e Fluorescence microscopy of LC3 shows
increased puncta formation in amino-acid-starved SMC that is lost with H2O2 co-treatment. The graph below shows quantiﬁcation of LC3 puncta from
treated SMC. f Direct induction of autophagosome nucleation in HEK cells by tat-beclin1 peptide induces LC3 lipidation, which is inhibited by H2O2
treatment in the presence or absence of baﬁlomycin A1. The graph below shows quantiﬁcation of LC3 lipidation from HEK cells treated with tat-beclin1. All
data represent mean± s.e. from 3 (a, b, f) or 4−7 (c) independent experiments. *P< 0.05, **P< 0.01, ***P< 0.005 statistical signiﬁcance relative to
control or baﬁlomycin A1 alone. †P< 0.05, ††P< 0.01, †††P< 0.005 statistical signiﬁcance (Dunnett’s test) relative to EBSS, tat-beclin1 or either combined
with baﬁlomycin A1
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correlated between Atg7 and LC3 immunoblots. In addition, this
supported the functional activity of overexpressed Atg7. As
anticipated, HEK cell overexpressing Atg7 were signiﬁcantly
protected from a loss in LC3 lipidation in amino-acid-deprived
cells exposed to H2O2 (Fig. 4c). Furthermore, the formation of a
disulﬁde-bound heterodimer between Atg3 and Atg7, under
oxidizing conditions, was substantiated by siRNA knock-down
of either enzyme. The knock-down of Atg3 attenuated
Atg7 disulﬁde formation, and loss of Atg7 prevented the
disulﬁde dimerization of Atg3 (Fig. 5a). Furthermore,
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immunoprecipitation of Atg7 led to co-puriﬁcation of the higher
molecular weight oxidized complex for mCherry-Atg3, thus
conﬁrming formation of a disulﬁde-bound heterodimer (Fig. 5b).
To conﬁrm if catalytic thiols on Atg3 and Atg7 were sites of
oxidation responsible for formation of the disulﬁde-bound het-
erodimer, we generated cysteine to alanine mutants. In trans-
fected SMC, an intermolecular disulﬁde could be observed
between wild-type mCherry-Atg3 and wild-type Atg7 after amino
acid starvation and H2O2 treatment (Fig. 5c, Supplementary
Fig. 5D). However, mutation of either the catalytic thiol on Atg3
(C264A) or Atg7 (C572A) prevented disulﬁde formation, thus
conﬁrming the active site thiols as the targets of oxidation.
Endogenous cellular oxidants inhibit LC3 lipidation. Elevations
in endogenous ROS formation compromises the cellular reducing
system by oxidizing the constituent reducing enzymes31,32.
Therefore, during conditions when oxidants are elevated, as
commonly occurs during disease, we hypothesized that impair-
ment of the reducing system could prevent the reduction of Atg3
and Atg7 required to maintain catalytic activity. To assess how
loss in the reducing system during oxidative stress may impact on
autophagy induction, we selectively attenuated thioredoxin
activity by overexpressing its endogenous inhibitor, thioredoxin-
interacting protein (TXNIP)33. The overexpression of TXNIP in
HEK cells signiﬁcantly attenuated LC3 lipidation in response to
amino acid withdrawal, observed in the presence or absence of
baﬁlomycin A1 (Fig. 6a). Despite this, TXNIP overexpression did
not mitigate the loss in covalent interaction between LC3 and both
Atg3 and Atg7 after amino acid starvation (Fig. 6b). Therefore,
loss in LC3II formation is consistent with enhanced Atg3 and
Atg7 oxidation that prevents interaction and lipidation of LC3.
The ability of endogenous oxidants to inhibit LC3 lipidation
was further substantiated using the pro-atherogenic lipoprotein
oxLDL. When SMC were exposed to oxLDL, the basal lipidation
of LC3 was inhibited (Fig. 6c). This loss in LC3 lipidation was due
to increased Atg7 oxidation, which generated an oxidized
complex at a molecular weight consistent with a disulﬁde-
bound Atg3 heterodimer (Fig. 6d). The ability of oxLDL to induce
detectable Atg7 oxidation without the need for amino acid
deprivation was likely due to activation of the autophagy
pathway. This is supported by a loss in Atg3 covalent interaction
with LC3 upon treatment of SMC with oxLDL, consistent with
upstream enzyme activation comparable to that of amino acid
deprivation. As tissue aging is also associated with loss in cellular
autophagy and elevated oxidant formation, we next assessed a
potential role for Atg3 and Atg7 oxidation. In aged mice, the
lipidation of aortic LC3 and a loss in p62 induced by 24-h food
withdrawal was signiﬁcantly impaired when compared to a
younger cohort of mice (Fig. 7a). Consistent with this observation
and enhanced oxidative stress, older mice had signiﬁcantly
increased disulﬁde oxidized Atg7, at a molecular weight
consistent with a disulﬁde-bound Atg3 heterodimer. Further-
more, the presence of a more oxidizing environment within the
aorta of aged mice was further substantiated by detection of
hyperoxidized peroxiredoxin (prx), which was signiﬁcantly higher
after starvation (Fig. 7b)31. Also, consistent with an increase in
oxidative stress in aged starved mice, carbonylation of plasma
proteins was signiﬁcantly enhanced (Fig. 7c). Therefore, an
increased oxidizing environment within aged tissue leads to
oxidation of Atg3 and Atg7, which decreases the ability to
upregulate LC3 lipidation.
Discussion
The discovery of a molecular mechanism for inhibiting autophagy
induction by cellular oxidants is perhaps surprising, as oxidants
are considered inducers of this catabolic process34. However, this
is partially based on studies where activation of autophagy is
observed after prolonged exogenous oxidant treatment, often for
24−48 h. After such prolonged treatment, it is likely that the
initial oxidant will have been fully consumed by the replete cel-
lular antioxidant and reducing systems. Therefore, acute inhibi-
tory effects may be missed with observed increases in autophagy
representing an adaptive cellular response. In addition, studies
often do not consider the impact of autophagy ﬂux on its sensi-
tivity to regulation by ROS. This is because it is routine to
monitor the impact of ROS on autophagy in cells where this
process is unstimulated, therefore making an inhibitory effect
difﬁcult to observe. Furthermore, compartmentalized changes in
ROS formation are likely to have disparate effects on autophagy.
Certainly, there is evidence that physiological ROS formation can
induce autophagy. This is through activation of select targets
including ataxia-telangiectasia mutated and AMPK, by elevation
in localized forms of ROS35,36. Whereas, under conditions of
dysregulated oxidant formation or impairment in cellular redu-
cing system, it is conceivable that oxidative modiﬁcation of
additional targets may prevent this catabolic process. Certainly,
this is consistent with increased oxidants derived from nicotina-
mide adenine dinucleotide phosphate-oxidase isoform 2 (Nox2) in
a mouse model of Duchenne muscular dystrophy37. In this mouse
model, increased Nox2-derived oxidants led to impaired autop-
hagy, which caused enhanced contractile dysfunction that is
associated with the pathology of this muscular degenerative disease.
In this study, we used H2O2 to mimic oxidative stress with
concentrations selected based on previous studies and suitability
Fig. 2 Atg3 and Atg7 form stable covalent intracellular complexes with LC3 and are sensitive to catalytic thiol oxidation. a In HEK cells the conjugation of
Atg5 and Atg12 remained unaffected by amino acid withdrawal or co-treatment with H2O2. However, Atg3 and Atg7 are able to form stable covalent
complexes with LC3 that decrease during amino acid withdrawal. The graphs to the right show quantiﬁcation of Atg3-LC3 and Atg7-LC3 from treated HEK
cells. b The higher molecular weight complexes for Atg3 and Atg7 can also be observed in HEK cells when immunoblotted for LC3, and are selectively
hydrolyzed by hydroxylamine or reduced by beta-mercaptoethanol. c LC3 covalently bound to Atg3 and Atg7 is co-puriﬁed when myc-tagged LC3 is
immunoprecipitated. d Stable covalent complexes between LC3 and either Atg3 or Atg7 can also be observed in SMC, where it decreases upon amino acid
withdrawal. In addition, when amino acids are withdrawn Atg7 is able to form a higher molecular weight (~130 kDa) oxidized complex in the presence of
H2O2. The graphs below show quantiﬁcation of Atg3-LC3 and Atg-LC3 from treated SMC. e The higher molecular weight oxidized complex detected for
Atg7 at approximately 130 kDa can also be observed for Atg3 on a higher exposure and is reducible only with beta-mercaptoethanol, thus supporting the
potential formation of an intermolecular disulﬁde bond between these two enzymes when exposed to H2O2. f Structure of the yeast complex between Atg3
and Atg7 (4GSL) showing close proximity of catalytic thiols. g In HEK cells oxidation of Atg3 and Atg7 can be observed in amino-acid-starved cells
exposed to H2O2, detected by a mobility shift following the PEG-switch assay. The graphs to the right show quantiﬁcation of Atg3, Atg7, Atg4, Atg10, and
PKGIα oxidation from treated HEK cells. h Amino acid deprivation induced lipidation of overexpressed wild-type and C-terminal truncated LC3 (ΔC), which
was attenuated by H2O2 in the presence or absence of baﬁlomycin. All data represent mean± s.e. from 5–8 (a) or 3 (d, g) independent experiments. *P<
0.05, **P< 0.01, ***P< 0.005 statistical signiﬁcance (Dunnett’s test) relative to control. †P< 0.05, ††P< 0.01, †††P< 0.005 statistical signiﬁcance
relative to EBSS treatment
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for mimicking pathological conditions28,38,39. Here we found
increased lipidation of LC3 by amino acid deprivation was
robustly attenuated in HEK and SMC by exogenous H2O2
treatment, which was due to direct enzyme oxidation indepen-
dent of protein expression. Loss in LC3 lipidation prevented its
transport to autophagic vacuole membranes, where it is known to
play an important role in autophagosome maturation7–10. The
inhibition of LC3 lipidation in HEK cells required a higher dose
of H2O2 compared to SMC, perhaps reﬂecting a more reductive
environment within the kidney cells40. However, in SMC a
concentration of 100 μM H2O2 was sufﬁcient in attenuating the
lipidation of LC3 during an hour of amino acid deprivation. The
ability of H2O2 to also inhibit tat-beclin1-induced LC3 lipidation
allowed us to narrow down the target(s) of oxidation responsible
for inhibiting LC3 lipidation, by focusing on those downstream of
beclin123. This led us to speculate that the targets of oxidation
were Atg3 and Atg7. The rationale being Atg3 and Atg7 have
surface accessible catalytic cysteine thiols that bind to LC3.
Therefore, oxidation of these cysteines would logically prevent
LC3 interaction and PE conjugation. On analyzing Atg3 and Atg7
under non-reducing conditions we observed stable covalent
complexes with LC3 under fed conditions. The ability of beta-
mercaptoethanol to cleave the thio-ester bond linking LC3 to
both Atg3 and Atg7 likely explains why stable covalent complexes
have not been previously reported in cultured mammalian cells or
tissue, as it is routine to resolve samples under reducing condi-
tions. The induction of autophagy by amino acid withdrawal
decreased the stable covalent interaction between LC3 and Atg7
in HEK cells, and between LC3 and both Atg3 and Atg7 in SMC.
A rational explanation for this loss in stable covalent interaction
is due to increased conjugase activity, where LC3 is actively
transferred between active site thiols on Atg7 to Atg3 then
attached to PE before being released. Activation of Atg3 is sti-
mulated by its membrane-curvature-sensing domain upon for-
mation of autophagosomal lipid bilayers during amino acid
withdrawal6. Therefore, loss in detectable LC3 covalent interac-
tion provides a measure of autophagy induction, as it directly
correlates with upstream activation of Atg3 and Atg7. The loss in
covalent LC3 interaction with Atg3 and Atg7 during amino acid
withdrawal sensitized these enzymes to oxidant-dependent
intermolecular disulﬁde bond formation within SMC. This is
consistent with oxidation of the catalytic cysteine thiols, which
are more accessible during autophagy activation, due to loss in
covalent-bound LC3. This is also consistent with the crystal
structure of yeast Atg3 and Atg7, where each enzyme has a
conserved catalytic site that is closely aligned, allowing transfer of
LC3 but also enough proximity for intermolecular disulﬁde for-
mation (Fig. 2e)27. In HEK cells there was a lack of intermolecular
disulﬁde detection, which could be explained by the enhanced
occupancy of the catalytic site on Atg3 with LC3 during amino
acid withdrawal compared to SMC, which is 10.5% higher. This
increase in bound LC3 on Atg3 diminishes the likelihood of both
enzymes in a complex having catalytic cysteines free to form a
disulﬁde. However, if either Atg3 or Atg7 alone have an
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Fig. 3 Atg3 and Atg7 form stable covalent complexes with LC3 and are sensitive to oxidative inhibition. a Reducible higher molecular weight complexes
corresponding to LC3-bound Atg3 and Atg7 can be observed for recombinant enzymes, in addition to a disulﬁde-bound Atg7 dimer. The formation of a
stable complex between LC3 and Atg3 requires Atg7, and liposomes are needed for LC3 lipidation. b The lipidation of LC3 in a complete reaction mixture
increases over 60min and stable complexes with Atg3 or Atg7 can be reduced by beta-mercaptoethanol. c Oxidized glutathione (GSSG) inhibited the
lipidation of LC3 in a complete reaction mixture, and decreased LC3 covalent-bound to Atg3 and Atg7
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Fig. 4 Atg7 overexpression attenuates oxidant-dependent loss in LC3 lipidation. a The interaction between Atg3 and Atg7 detected using a PLA assay did
not change upon amino acid withdrawal. However, H2O2 treatment prevented interaction only in amino-acid-deprived cells, thus consistent with direct
oxidation preventing Atg3 and Atg7 interaction. b Atg7 overexpression increases the quantity of LC3 that is covalently bound to Atg7, detected on Atg7
and LC3 immunoblots. c Atg7 overexpression preserves the lipidation of LC3 in amino-acid-starved cells treated with H2O2. The graph to the right shows
quantiﬁcation of LC3 lipidation from treated mock or Atg7 transfected HEK cells. All data represent mean± s.e. from three independent experiments. *P<
0.05 statistical signiﬁcance (Dunnett’s test)
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unoccupied catalytic cysteine within the same complex then
reversible thiol oxidation can occur, which was detected using the
PEG-switch assay, and would likely result in S-glutathiolation. As
well as Atg3 and Atg7 oxidation, we detected reversible thiol
modiﬁcation of cellular Atg4B and Atg10 by H2O2. These
enzymes contain catalytic thiols, with Atg4B having been pre-
viously described as a target of oxidation29. However, the oxi-
dation of Atg10 did not impact on conjugation of Atg5 to Atg12
needed for LC3 lipidation4. In addition, loss of LC3 lipidation by
H2O2 was found to be independent of Atg4B. It is perhaps
unsurprising that the oxidation of Atg10 and Atg4B is not
responsible for the rapid loss in LC3 lipidation observed in cells
exposed to H2O2, as these enzymes are constitutively active. As
Atg5 and Atg12 are fully conjugated and LC3 already cleaved,
Atg10 or Atg4 would have to remain inhibited by thiol oxidation
over an extensive period (requiring de novo protein synthesis) to
impact on LC3 lipidation, which would already be impaired by
Atg3 and Atg7 oxidation. However, it cannot be ruled out that
regulators of autophagosome formation upstream of Atg3 and
Atg7 may also undergo redox regulation that impacts on the
acute regulation of autophagy.
The reversible oxidation of Atg3 and Atg7 detected using the
PEG-switch assay is likely S-glutathiolation due to the high cel-
lular abundance of GSH. This is consistent with the direct
reversible inhibition of the highly homologous ubiquitin-
activating enzyme (E1) and ubiquitin-conjugating enzymes (E2)
through oxidative S-glutathiolation of their catalytic thiols41.
Furthermore, this would mean the oxidant-induced inter-
molecular disulﬁde between Atg3 and Atg7 observed in SMC is
likely to be an underestimate of total reversible inhibitory oxi-
dation. This is due to additional S-glutathiolation of catalytic
cysteines on either Atg3 or Atg7 when the adjacent enzyme in the
complex is bound to LC3 (Fig. 8). In addition, as autophagy
activation is required for Atg3 and Atg7 oxidation, this explains
why inhibition of this catabolic process by ROS has not been
widely observed. This is because the impact of oxidants on
autophagy is routinely analyzed in cells where this process is
unstimulated, thus limiting the ability of Atg3 and Atg7 to
undergo oxidation.
Excessive autophagy can drive cell death through a process
termed autosis42. It is therefore conceivable that oxidant-
dependent inhibition of Atg3 or Atg7 could preserve cell integ-
rity when this catabolic process is overly stimulated. However,
extended treatment with H2O2 is likely to compromise cell
integrity through activation of apoptopic or necrotic pathways43.
Therefore, development of therapies that selectively target thiols
on Atg3 or Atg7 may provide a mechanism for preventing
autosis, without the risk of compromising cell integrity.
As well as LC3, its paralogs GABARAPL1 and 2 are substrates
for Atg3 and Atg7, were also found to form stable covalent
complexes within cultured cells. The molecular weights of these
complexes were consistent with covalent bound Atg3 or Atg7.
During autophagy the lipidation of GABARAPL1 and 2 is crucial
in the late stage of autophagosome biogenesis, as it is required for
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Fig. 5 Under pro-oxidizing conditions a disulﬁde forms between the catalytic thiols of Atg3 and Atg7. a siRNA knock-down of Atg7 attenuates
intermolecular disulﬁde oxidation of Atg3, and loss of Atg3 prevents Atg7 disulﬁde dimerization. b Immunoprecipitation of Atg7 leads co-puriﬁcation of
disulﬁde-bound mCherry-Atg3. c Overexpressed wild-type mCherryAtg3 and wild-type Atg7 form a disulﬁde-bound heterodimer in amino-acid-starved
cells treated with H2O2. However, mutation of the catalytic thiol to an alanine on either Atg3 or Atg7 prevents intermolecular disulﬁde formation
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sealing the isolation membrane8. Therefore, it is likely that oxi-
dation of Atg3 and Atg7 will also prevent the lipidation of
GABARAPL1 and 2, enzymes that are essential for autophago-
some maturation.
The interaction of Atg3 and Atg7 required for transfer and
lipidation of LC3 was found to be inhibited by enzyme oxida-
tion27. As the interaction between Atg3 and Atg7 was only dis-
rupted by H2O2 when cells were deprived of amino acids, this
suggests that oxidation of the active site residue(s) is responsible
for this observation. This is likely due to the addition of a bulky
glutathione moiety to the enzymes active site, which either
directly or through a conformational change prevents enzyme
interaction. Furthermore, this highlights the likely under-
estimation of intermolecular disulﬁde bond formation between
Atg3 and Atg7 as a measure of total inhibitory enzyme oxidation.
In an in vitro lipidation assay, oxidized glutathione prevented
LC3II formation that was consistent with Atg3 and Atg7 catalytic
thiol oxidation through S-glutathiolation. This substantiated
ﬁndings from cell studies, as oxidation of Atg3 and Atg7 alone is
sufﬁcient in preventing LC3 lipidation. In addition, in vitro
lipidation assays conﬁrmed the formation of stable covalent
complexes between LC3 and both Atg3 and Atg7. Furthermore,
in an attempt to mitigate the effects of H2O2 on LC3 lipidation,
we increased the intracellular pool of reduced Atg7. Here over-
expression of Atg7 improved LC3 lipidation in amino-acid-
starved cells exposed to H2O2. This ﬁnding further substantiated
the importance of Atg7 oxidation in mediating the inhibition of
autophagy, but also provides a potential strategy to improve
autophagy ﬂux under conditions of oxidative stress. In addition,
the formation of a disulﬁde-bound Atg3 and Atg7 heterodimer
under oxidizing conditions was conﬁrmed, as siRNA knock-down
of either enzyme attenuated covalent complex formation. Here
the catalytic thiol of Atg3 and Atg7 was identiﬁed as the site of
oxidation, as mutation of the active site cysteine on either enzyme
prevented disulﬁde-dependent heterodimerization.
The impact of endogenous oxidant formation on acute
autophagy induction was also investigated by attenuating the
cellular thioredoxin reducing system, using overexpression of the
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Fig. 6 Inhibition of the thioredoxin-reducing system or oxLDL treatment prevents LC3 lipidation. a The overexpression of TXNIP in HEK cells but not EGFP
signiﬁcantly attenuates LC3 lipidation in response to amino acid withdrawal, observed in the presence or absence of baﬁlomycin A1. The graph below
shows quantiﬁcation of LC3 lipidation from treated EGFP or TXNIP transfected HEK cells. b During amino acid withdrawal the loss in LC3 interaction with
Atg3 and Atg7 is maintained in cells overexpressing TXNIP or EGFP. The graphs below show quantiﬁcation of Atg3-LC3 and Atg7-LC3 formation from
treated EGFP or TXNIP transfected HEK cells. c Treatment of SMC with oxLDL signiﬁcantly attenuates basal LC3 lipidation and leads to accumulation of
LC3I. The graphs to the right show quantiﬁcation of LC3I and LC3II from control, EBSS or oxLDL-treated SMC. d oxLDL induces Atg7 oxidation and
signiﬁcantly decreases the covalent interaction between Atg3 and LC3. The graphs to the right show quantiﬁcation of Atg7 oxidation, Atg3-LC3 and Atg7-
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Fig. 7 Loss in LC3 lipidation and increased Atg7 oxidation in aged mouse aorta. a Aged mice have impaired aortic LC3 lipidation, higher expression of p62,
and loss of LC3-Atg7 in response to 24-h food withdrawal. In addition, aged mice had increased Atg7 oxidation in their aortic vessels, at a molecular weight
consistent with a disulﬁde-bound Atg3 heterodimer. The graphs to the right show quantiﬁcation of LC3 lipidation, p62, Atg7 oxidation, Atg3-LC3, and
Atg7-LC3 formation in aorta from fed or starved young or aged mice. b The hyperoxidation of prx (Prx-SO3) was signiﬁcantly enhanced in aortic vessels of
aged mice after 24-h food withdrawal. The graph to the right shows quantiﬁcation of Prx-SO3 in aorta from fed or starved young or aged mice. c Plasma
protein carbonylation is signiﬁcantly enhanced in aged starved mice. The graph to the right shows quantiﬁcation of carbonylated plasma proteins from fed
or starved young or aged mice. All data represent mean± s.e. from 8–9 (a, b) mice/group except for analysis of p62 expression and plasma protein
carbonylation (c) which was using ﬁve mice/group. *P< 0.05, **P< 0.01, statistical signiﬁcance (Dunnett’s test) relative to young fed mice. †P< 0.05,
†††P< 0.005 statistical signiﬁcance relative to young starved mice
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endogenous thioredoxin inhibitor TXNIP33. Inhibiting the cel-
lular thioredoxin reducing system signiﬁcantly attenuated lipi-
dation of LC3 induced by amino acid withdrawal. In addition,
TXNIP overexpression did not reverse the loss in covalent
interaction between LC3 and both Atg3 and Atg7 after amino
acid withdrawal. Consequently, inhibiting the cellular thioredoxin
reducing system did not appear to impact on the upstream
activation of Atg3 and Atg7 during amino acid starvation, con-
sistent with normal autophagosome nucleation. Therefore, loss in
LC3 lipidation when inhibiting thioredoxin is likely through
enhanced inhibitory Atg3 and Atg7 catalytic thiol oxidation.
Therefore, these ﬁndings provide evidence that an active cellular
reducing system is required to maintain functional autophagy,
likely by keeping the active site thiols of Atg3 and Atg7 reduced to
preserve their ability to interact with LC3. To further assess the
role of intracellular oxidant formation on autophagy induction we
treated aortic SMC with oxLDL. The rational for selecting oxLDL
was its relevance to aortic SMC pathophysiology, which is asso-
ciated with elevated endogenous oxidant formation. Certainly,
oxLDL has been implicated in the development of atherosclerotic
plaque formation, which is attributed in part to increased vascular
smooth muscle cell (VSMC) death. This ability of oxLDL to
induce VSMC apoptosis is dependent on ROS generated by
lipoxygenase and mitochondrial pathways44,45. Treatment of
amino-acid-fed SMC with oxLDL prevented the lipidation of
LC3. This observation was consistent with the ability of oxLDL to
increase ROS, conﬁrmed by elevated disulﬁde oxidation of Atg7,
which generated a molecular weight complex corresponding to
bound Atg3. The ability of oxLDL to induce detectable Atg7
oxidation in fed cells is likely due to its ability to stimulate the
autophagy pathway, observed by a loss in covalent LC3 bound to
Atg3 that is comparable to amino acid deprivation. Activation of
the autophagy pathway by oxLDL would decrease covalent-bound
LC3, providing increased access of the catalytic thiol on Atg3 to
disulﬁde oxidation. With a concomitant increase in oxidant
generation, this could explain how oxLDL promotes formation of
an oxidized higher molecular weight complex for Atg7 and pre-
vents LC3 lipidation.
To fully validate the importance of Atg3 and Atg7 oxidation in
regulating autophagy, this process was assessed in a relevant
in vivo model. We chose to use a mouse model of aging, as this
process is causatively linked to a loss in autophagy ﬂux and
enhanced oxidant formation14,21. Following our observations in
cultured aortic SMC we assessed autophagy ﬂux in the aorta of
fed and food-deprived mice at 12 and 68 weeks of age. In food-
deprived mice the lipidation of LC3 was impaired and abundance
of p62 increased in aorta of aged compared to young mice,
consistent with dysfunctional autophagy induction. This impair-
ment in autophagy correlated with an increase in inhibitory Atg7
oxidation in aged mouse aorta, which generated a molecular
weight complex consistent with disulﬁde-bound Atg3. The
increased oxidizing environment in aged mouse aorta that
accounted for Atg7 oxidation was further supported by increased
prx hyperoxidation and plasma protein carbonylation, which
signiﬁcantly increased in aged mice after 24-h food withdrawal31.
To conclude we have identiﬁed a process for the thiol-
dependent regulation of autophagy, through oxidation of Atg3
and Atg7, which prevents PE conjugation to LC3 required for
autophagosome maturation. Stable covalent complexes identiﬁed
between LC3 and both Atg3 and Atg7 protects each enzyme from
inhibitory oxidation. However, under conditions where autop-
hagy is stimulated, loss in stable LC3 interaction enhances the
susceptibility of Atg3 and Atg7 to direct oxidative inactivation.
This mechanism is likely to play an important role in regulating
autophagy, including its loss during aging, as well as providing
therapeutic targets to regulate autophagosome maturation.
Methods
Cell culture. SMC were isolated from explanted rat aorta. In brief, isolated rat aorta
was cleaned of fat and connective tissue, opened lengthways and cut into sections.
Sections of aorta were placed lumen side down in tissue culture plates and covered
with media (Dulbecco’s modiﬁed eagle medium ((DMEM) supplemented with 10%
fetal calf serum (FCS) and 1% pen/strep) to encourage SMC growth onto the plate
surface. Once SMC had grown and adhered onto the plate, the aortic sections were
removed, with cells then maintained in culture media. SMC and HEK (240073,
stratagene) cells were cultured in DMEM (GIBCO, Life Technologies) supple-
mented with 10% FCS and 1% penicillin/streptomycin and kept at 37 °C in an
incubator with 5% CO2. To induce autophagy cells were rinsed and then incubated
with Earle’s balanced salt solution (EBSS) for 1 h. At the initiation of starvation
some cells were exposed to H2O2 and/or 100 nM baﬁlomcyin A1. In some
experiments HEK cells were transfected for 24 h with 100 ng of EGFP (Addgene,
gift from Benjamin Glick, 18758), 100 ng of EGFP-TXNIP (Addgene, gift from
Clark Distelhorst, 36412), 10 ng of Atg7 (Sino Biological, HG15684-UT), 10 ng
pCMV-myc-LC3 (Addgene, gift from Toren Finkel, 24919) or 10 ng pCMV-myc-
LC3 ΔC DNA using lipofectamine 2000 (Invitrogen) before treatment46,47. The
pCMV-myc-LC3 ΔC was generated to express a truncated form of human LC3
without the C-terminal 5 amino acids (MKLSV) normally cleaved by Atg4. pCMV-
myc-LC3 ΔC was generated from wild-type by introducing a premature stop codon
using site directed mutagenesis (QuikChange II XL, Agilent) following the man-
ufacturer’s instructions. In some experiments, SMC were transfected for 48 h with a
combination of 250 ng of wild-type mCherryAtg3 (Addgene, 54993), C264A
mCherryAtg3, wild-type Atg7 (Sino Biological, HG15684) or C572A Atg7 using
lipofectamine 3000. In other experiments SMC were treated with human oxLDL
(Alfa Aesar) in complete growth media for the indicated time. To inhibit protein
synthesis SMC were preincubated for 1 h with 100 μg/ml cycloheximide before a
further 1 h treatment with baﬁlomycin in combination with or without EBSS or
H2O2. In experiments assessing cell viability, after treatment cells were detached
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using trypsin-EDTA (ThermoFisher), diluted into trypan blue, and then percentage
of stained cells analyzed using an automated cell counter (TC20, Bio-Rad). When
assessing cellular caspase-3 cleavage a positive control was generated by treating
cells for 6 h with 3 μM staurosporine (Sigma), and for assessing proteasomal
degradation SMC were pretreated for 30 min with 10 μM MG132, then co-treated
with experimental reagents for 1 h. To knock-down expression of Atg3 or Atg7
SMC were transfected with siRNA (ON-TARGETplus SMARTpool siRNA,
Dharmacon) using Lipofectamine 3000, following the manufacturer’s instructions.
Forty-eight hours after transfection cells were left in complete media or amino acid
starved in the presence or absence of H2O2 for 1 h, before lysis into non-denaturing
sample buffer containing maleimide. To monitor intracellular ROS SMC or HEK
cells seeded on 96-well plates were pre-treated with 5 µM 6-carboxy-2′,7′-dichlor-
odihydroﬂuorescein diacetate (carboxy-H2DCFDA, ThermoFisher), in DMEM
containing 2% FCS for 30 min in a 37 °C culture incubator. After incubation media
was exchanged with control media or autophagy stimulated (EBSS or tat-belcin1)
in the presence or absence of H2O2. Cells were then maintained at 37 °C for 1–3 h
before being assessed for carboxy-H2DCFDA ﬂuorescence (λex 595 nm; λem 520
nm) using a plate reader (SpectraMax GeminiXS, Molecular Devices).
Quantitative PCR analysis. mRNA from SMC that were fed, amino acid starved
or amino acid starved and H2O2 treated for 1 h was isolated and reverse transcribed
using a TaqMan gene expression cells-to-CT kit (ThermoFisher). Quantitative PCR
was performed using TaqMan gene expression assays and a StepOnePlus Real-
Time PCR System using the manufacturer’s instructions. Samples were assessed for
LC3A (Rn00458724_g1, ThermoFisher) and LC3B (Rn00575883_m1, Thermo-
Fisher) gene expression, as well as β-actin (Rn00667869_m1, ThermoFisher) as an
internal control. Although LC3A transcripts could be detected, due to the low
expression of LC3B in SMC, we were unable to reliably measure its gene
expression.
Autophagy induction using tat-beclin1. A cell-permeable autophagy inducing
peptide (Tat-beclin1, Eurogentec) consisting of the autophagy essential residues of
beclin1 and the HIV virus Tat sequence was used to induce autophagy. The peptide
(50 µM) was administered to cells as previously described for 3 h in OPTIMEM
acidiﬁed with 15% (vol/vol) 6 N HCl23. In some experimental groups 100 nM
baﬁlomcyin A1 was also included, and 1 h after incubation some groups were
exposed to H2O2.
Immunoblotting. After incubation cells were lysed directly into sample buffer (50
mM Tris-HCl buffer pH 6.8, 2% SDS, 10% glycerol, 0.005% bromophenol blue)
containing 100 mM maleimide to preserve protein oxidation. Protein samples were
resolved on SDS-PAGE gels and then transferred to polyvinylidene diﬂuoride
membranes by western blotting (TransBlot Turbo, Bio-Rad). Membranes were
blocked in milk dissolved in phosphate-buffered saline (PBS) supplemented with
1% Tween before incubation with primary antibodies. Membranes were developed
using enhanced chemiluminescence substrate (ThermoFisher) and detected using
photographic ﬁlm, which was developed using an automatic processor (Fuji RG II).
Samples were immunoblotted for LC3 (1:1000, Cell Signaling), Atg3 (1:5000,
Abcam), Atg7 (1:1000, Cell Signaling), Actin (1:10,000, Sigma), Atg5 (1:1000, Cell
Signaling), Atg12 (1:1000, Cell Signaling), Atg4B (1:1000, Cell Signaling), Atg10
(1:1000, Abcam), GABARAPL1 (1:1000, Cell Signaling), GABARAPL2 (1:1000,
Cell Signaling), cGMP-dependent protein kinase (PKG, 1:1000, ENZO Life Sci-
ences), Myc-tag (1:1000, Cell Signaling), p62 (1:500, Cell Signaling), caspase-3
(1:1000, Abcam), peroxiredoxin-SO3 (1:500, AbFrontier) and GFP (1:2000, Mil-
tenyi Biotec). All uncropped western blots can be found in Supplementary Fig. 6.
Immunoprecipitation. HEK cells were mock or myc-LC3 DNA transfected for 24
h and then either left in complete media or amino acid starved for 1 h. Alter-
natively, SMC were transfected with Atg7 and mCherry-Atg3 for 48 h before being
left untreated or amino acid starved for 1 h with 100 μM H2O2 co-treatment. After
incubation cells were rinsed in PBS and then lysed into ice-cold PBS containing 1%
Triton X-100 and protease inhibitors (cOmplete, Roche). Cell lysates were then
centrifuged at 250,000 r.p.m. for 5 min at 4 °C to pellet insoluble material. Super-
natants were added to magnetic beads conjugated to myc-tag antibody (Cell Sig-
naling), with some also added to sample buffer for immunoblot analysis. After 24 h
incubation at 4 °C, beads were washed ﬁve times with PBS containing 1% Triton-
X100. Bound proteins were then eluted by addition of sample buffer and assessed
by immunoblot analysis.
Electron microscopy analysis. SMC grown on coverslips were left untreated or
placed into EBSS for 1 h with or without the addition of H2O2. After incubation
cells were washed three times with PBS then ﬁxed for 1 h in 4% (wt/vol) paraf-
ormaldehyde before being permeabilized for 15 min using 40 μg/ml digitonin.
Permeabilized cells were then blocked for 30 min in 1% (wt/vol) bovine serum
albumin (BSA) solubilized in PBS before being immuno-labeled with an anti-LC3
antibody (CAC-CTB-LC3–2-IC, Cosmo Bio) diluted to 1:80 in the same buffer.
After 2 h incubation cells were washed with PBS and then incubated for a further 2
h with secondary anti-mouse nano-gold (Universal Biologicals) diluted to 1:200 in
1% (wt/vol) BSA solubilized in PBS. After incubation cells were then ﬁxed for a
second time using 2% (wt/vol) PFA/2% (vol/vol) glutaraldehyde in 0.15 M caco-
dylate buffer for 1 h. To increase the size of nano gold particles, cells were sub-
sequently incubated with GoldEnhance EM Plus (Nanoprobes) for 15 min in
accordance with the manufacturer’s instructions. The cells were then incubated in
1% (vol/vol) osmium tetroxide/1% (wt/vol) potassium ferrocyanide for 1 h fol-
lowed by 1% (wt/vol) uranyl acetate for an additional hour. Using increasing
concentrations of ethanol followed by propylene oxide, the cells were embedded in
epon resin. Sections (~100 nm) were cut and images were acquired on a JEOL 1010
transmission electron microscope. Autophagic vacuoles were identiﬁed by the
presence of membrane like-structures with LC3 immuno-gold labeling.
PEG-switch assay. Reversible protein oxidation was assessed as previously
described using the PEG-switch assay48. In brief untreated cells or those starved for
1 h in EBSS with or without H2O2 co-treatment were lysed into alkylating buffer
(1% SDS, 100 mM maleimide, 100 mM Tris-HCl pH 7.4) and then heated at 50 °C
for 25 min. Alkylated samples were then supplemented with 200 mM dithiothreitol
(DTT) to quench the maleimide and reduce reversibly oxidized thiols. After 30 min
incubation, each sample was desalted (Zeba columns, Peirce) and eluted into
labeling buffer (10 mM PEG-maleimide, 1% SDS and 100 mM Tris-HCl pH 7.4).
Following 2 h further incubation at room temperature samples were prepared for
SDS-PAGE by addition of sample buffer containing 5% beta-mecaptoethanol and
immunoblotted as described above.
LC3 lipidation assay. Phospholipids were purchased in chloroform. 2-oleoyl-1-
palmitoyl-sn-glycero-3-phosphocholine, 1,2-dioleoyl-sn-glycero-3-phosphoetha-
nolamine and 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (Avanti Polar Lipids)
were mixed in a 1:1:1 molar ratio in glass tubes and dried in a vacuum centrifuge to
remove any chloroform to produce a dried lipid ﬁlm. Dried lipids were recon-
stituted to a ﬁnal concentration of 1 mM in buffer (25 mM Tris-HCl pH 7.5, 137 mM
NaCl, 2.7 mM KCl). The lipid mixture was then vortexed vigorously and sonicated
on ice for 2 min to create unilamellar vesicles (liposomes). For the lipidation of
LC3, 30 µM liposome were mixed with 5 µM recombinant human His-MAP1LC3B
(Fitzgerald Industries), 1 µM of recombinant human His6-Atg3 and His6-Atg7
(R&D systems), 0.2 mM DTT and 10mM MgCl2 in reaction buffer (50 mM Tris-
HCl pH 7, 150 mM NaCl). Reactions were initiated by addition of 5 mM ATP and
incubated at 30 °C for up to 60 min before being terminated by the addition of
sample buffer containing either 5% 2-mecaptoethanol or 100 mM maleimide.
Samples were then resolved on SDS-PAGE gels and proteins stained using colloidal
Coomassie.
Confocal microscopy. Proximity ligation assay (PLA) was performed using the
Duolink In Situ kit (Sigma) following the manufacturer’s instructions. In brief,
SMC were left untreated or treated with EBSS with or without 100 µM H2O2 for 1 h
then ﬁxed in 4% paraformaldehyde for 10 min. After washing in PBS, cells were
permeabilized for 5 min in 0.2% Triton X-100. Cells were blocked for 1 h at 37 °C
then incubated overnight with primary Atg3 and Atg7 antibodies (Abcam) at 1:50
dilution. After washing to remove primary antibodies, Duolink probes were added
and cells were incubated at 37 °C for a further hour. Duolink Ligation solution was
prepared as described with the supplied ligase, with the reaction allowed to proceed
for 30 min at 37 °C. Duolink Ampliﬁcation solution was prepared as described and
polymerization proceeded for 100 min at 37 °C. Finally, slides were prepared for
confocal microscopy by adding coverslips with mounting media containing 4',6-
diamidino-2-phenylindole (DAPI). In separate experiments, LC3 localization was
assessed in fed or amino-acid-starved SMC after 1 h with or without H2O2 co-
treatment. These cells were ﬁxed and permeabilized as with the PLA, then incu-
bated with LC3 antibody (1:50, Cell Signaling) overnight at 4 °C. After washing to
remove primary antibody, Cy3 anti-rabbit secondary antibody (1:100, Jackson
ImmunoResearch) was added for 1 h at room temperature. After incubation cells
were washed and then coverslips added with mounting media containing DAPI. All
samples were analyzed using a Leica SP5 confocal microscope.
Isolation of mouse aorta. Mice were maintained in accordance with the Home
Ofﬁce Guidance. Male C57BL/6J mice at 12-weeks and 68-weeks of age were
purchased from Charles River. A cohort of young and aged mice were either kept
on a standard RM1 diet or deprived of food for 24 h. After 24 h each mouse was
anaesthetized and aorta carefully excised, cleaned of fatty tissue then rinsed in
sterile PBS. Once cleaned, vessels were snap frozen in liquid nitrogen. Frozen
vessels were then crushed under liquid nitrogen and placed into 5% wt/vol sample
buffer containing 100 mM maleimide. Proteins were analyzed by immunoblotting
as described above.
Detecting of plasma protein carbonylation. Whole blood was drawn from the
vena cava in the presence of heparin to prevent clotting, stored on ice and cen-
trifuged at 1000×g for 10 min at 4 °C. The upper separated layer of plasma, free of
red blood cells, was snap frozen in liquid nitrogen. Protein carbonyl content of
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02352-z ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:95 |DOI: 10.1038/s41467-017-02352-z |www.nature.com/naturecommunications 13
plasma samples was analyzed using an OxyBlot protein oxidation detection Kit
(Millipore). Protein (10 µg) from each plasma sample was denatured in 6% SDS in
duplicate; these were then subject to derivatization with DNPH solution or
derivatization-control solution for 15 min at room temperature. Samples were then
immunoblotted as described above using a DNP antibody (1:150) provided with
the OxyBlot kit. Total protein labeling in each lane was analyzed, with the band
observed at 60 kDa omitted from analysis, as labeling of this protein could not be
reliability assessed due to the extent of its modiﬁcation by DNP.
Statistical calculations. Results are presented as mean± standard error of the
mean (s.e.m.). Differences between groups were assessed using analysis of variance
followed by a two-tailed unpaired Student's t-test or for multiple comparisons a
Dunnett post-hoc analysis. Results were considered signiﬁcant at the 95% con-
ﬁdence level.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its supplementary information ﬁles or
from the corresponding author upon reasonable request.
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